Full Text
ND1 ESTIMATING COST-EFFECTIVENESS OF DRUGS THAT DELAY DISABILITY PROGRESSION IN MULTIPLE SCLEROSIS USING NET BENEFIT REGRESSION MODEL METHODS

Abstract

Authors

MG Brown JS Hoch D MacKinnon-Cameron

Back to Volume 7, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×